Clinical trials that target human endogenous retroviruses to treat multiple sclerosis, ALS, and other ailments are underway, but many questions remain about how these sequences may disrupt our biology.
Rashmi Shivni, Drug Discovery News | May 20, 2023 | 10 min read
George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.
Strategies to make lab animals forget, remember, or experience false recollections probe how memory works, and may inspire treatments for neurological diseases.
Our perception of quantity, separate from counting or estimation of magnitude more generally, is foundational to human cognition, according to some neuroscientists.
The 23-year-old neuroscience graduate student, born in Saudi Arabia and raised in numerous countries, came to the U.S. as a teenager to attend college.